Jefferies Downgrades Tango Therapeutics to Hold, Raises Price Target to $27

Benzinga Newsdesk www.benzinga.com Negative 78.9%

Neg 78.9% Neu 0% Pos 0%

Jefferies analyst Maury Raycroft downgrades Tango Therapeutics (NASDAQ:TNGX) from Buy to Hold and raises the price target from $18 to $27.